FDA Import Refusal AEK-5093489-0/51/1 — MINT PHARMACEUTICALS INC
The FDA refused shipment AEK-5093489-0/51/1 from MINT PHARMACEUTICALS INC (Canada) on Aug 8, 2024. The refused product falls under Drugs and Biologics — HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 8, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62LCY29 HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
- Charges
- 75